.jpg)
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Veterinary medicines European public assessment report (EPAR): Poulvac Procerta ...
After hundreds of FDA employees were suddenly laid off last weekend, including d...
Veterinary medicines European public assessment report (EPAR): Icthiovac ERM, in...
The United States has joined a WHO-led flu vaccine meeting, despite the Trump ad...
Detailed results presented at a medical congress help reinforce analyst expectat...
List of medicinal products under additional monitoring
Human medicines European public assessment report (EPAR): Breyanzi, lisocabtagen...
After leaving the FDA, where she served as director of the Center for Drug Evalu...
Pfizer has teamed up with Summit Therapeutics to assess whether one of the indus...
Human medicines European public assessment report (EPAR): Lyrica, pregabalin, Da...
Entrada Therapeutics is finally able to get its Duchenne muscular dystrophy cand...
Human medicines European public assessment report (EPAR): Kavigale, sipavibart, ...
The company said its approach has helped cut the number of discarded livers in h...
Looking to avoid a repeat of the shortages that plagued Mounjaro and Zepbound du...
The company said its U.S. rollout represents the largest-ever commercial launch ...
In this tracker, Fierce Pharma is recording the regulatory progress of in-market...
An approval for the first drug for a rare lipid storage disease, some FDA worker...
Revenues in the biopharma industry continued to boom in the fourth quarter of la...
Revenues in the biopharma industry continued to boom in the fourth quarter of la...
In today's Morning Rounds newsletter, a viral vaccine study, rehired FDA employe...
The Pfizer CEO at the White House, CDC vaccine efforts, and other crucial biotec...
Patrizia Cavazzoni, formerly the top regulator of the drug division of the FDA, ...
If the Trump administration truly wants to reduce waste and fraud in government ...